- Home
- CIB vs TECH Comparison
CIB vs TECH Comparison
Compare CIB & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIB
- TECH
- Stock Information
- Founded
- CIB 1945
- TECH 1976
- Country
- CIB Colombia
- TECH United States
- Employees
- CIB N/A
- TECH N/A
- Industry
- CIB Commercial Banks
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIB Finance
- TECH Health Care
- Exchange
- CIB Nasdaq
- TECH Nasdaq
- Market Cap
- CIB 10.2B
- TECH 7.8B
- IPO Year
- CIB 1995
- TECH 1989
- Fundamental
- Price
- CIB $46.45
- TECH $51.84
- Analyst Decision
- CIB Sell
- TECH Buy
- Analyst Count
- CIB 5
- TECH 11
- Target Price
- CIB $39.00
- TECH $72.00
- AVG Volume (30 Days)
- CIB 413.1K
- TECH 2.1M
- Earning Date
- CIB 08-07-2025
- TECH 08-06-2025
- Dividend Yield
- CIB 14.04%
- TECH 0.63%
- EPS Growth
- CIB 4.59
- TECH N/A
- EPS
- CIB 1.57
- TECH 0.83
- Revenue
- CIB $5,380,508,149.00
- TECH $1,208,770,000.00
- Revenue This Year
- CIB $21.80
- TECH $7.07
- Revenue Next Year
- CIB $5.91
- TECH $5.64
- P/E Ratio
- CIB $7.64
- TECH $61.55
- Revenue Growth
- CIB 6.91
- TECH 4.72
- 52 Week Low
- CIB $30.25
- TECH $46.01
- 52 Week High
- CIB $46.65
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- CIB 66.66
- TECH 55.82
- Support Level
- CIB $42.53
- TECH $49.27
- Resistance Level
- CIB $43.68
- TECH $53.41
- Average True Range (ATR)
- CIB 1.11
- TECH 1.79
- MACD
- CIB 0.24
- TECH 0.28
- Stochastic Oscillator
- CIB 91.06
- TECH 68.60
About CIB BanColombia S.A.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.